Search research articles
Contact Us
Filters
Showing results (711-720 of 831) with videos related to
Page
of 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2020
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Neelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, et al.
NPJ Breast Cancer
|
October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrence
Kimberly S Keene, Tari King, E Shelley Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood
Michaela J Higgins, Danijela Jelovac, Evan Barnathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2015
Reply to E.A. Rakha et al
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast Cancer
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)
Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole
Tatiana M Prowell, Amanda L Blackford, Celia Byrne, et al.
The New England Journal of Medicine
|
January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
Sara M Tolaney, William T Barry, Chau T Dang, et al.
Cancer Immunology Research
|
August 14, 2014
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer
Gang Chen, Richa Gupta, Silvia Petrik, et al.
ESMO Open
|
March 11, 2026
TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer
S Jacob, E L Mayer, N Kacik, et al.
Page
of 84
Search research articles
Search
Showing results (711-720 of 831) with videos related to
Sort By:
Page
of 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2020
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Neelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, et al.
NPJ Breast Cancer
|
October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrence
Kimberly S Keene, Tari King, E Shelley Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood
Michaela J Higgins, Danijela Jelovac, Evan Barnathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2015
Reply to E.A. Rakha et al
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast Cancer
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)
Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole
Tatiana M Prowell, Amanda L Blackford, Celia Byrne, et al.
The New England Journal of Medicine
|
January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
Sara M Tolaney, William T Barry, Chau T Dang, et al.
Cancer Immunology Research
|
August 14, 2014
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer
Gang Chen, Richa Gupta, Silvia Petrik, et al.
ESMO Open
|
March 11, 2026
TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer
S Jacob, E L Mayer, N Kacik, et al.
Page
of 84